Advanced search
Publication Cover
Future Oncology Volume 14, 2018 - Issue 21
Submit an article Journal homepage
11,169
Views
41
CrossRef citations to date
0
Altmetric
Clinical Trial Protocol

Accelerating Drug Development in Pediatric Cancer: A Novel Phase I Study Design of Venetoclax in Relapsed/Refractory Malignancies

Andrew E Place1 Dana-Farber/Boston Children’s Cancer & Blood Disorders Center, Boston, MA, USACorrespondence[email protected]
View further author information
,
Kelly Goldsmith2 School of Medicine, Emory University, Atlanta, GA, USAView further author information
,
Jean-Pierre Bourquin3 Cancer Research Center, University Children’s Hospital & Children’s Research Center, Zurich, SwitzerlandView further author information
,
Mignon L Loh4 Department of Pediatrics, Benioff Children’s Hospital & the Helen Diller Comprehensive Cancer Center, University of California, San Francisco, CA, USAView further author information
,
Lia Gore5 School of Medicine & Children’s Hospital Colorado, University of Colorado, Aurora, CO, USAView further author information
,
Daniel A Morgenstern6 Department of Paediatrics, Hospital for Sick Children & University of Toronto, Toronto, ON, CanadaView further author information
,
Yeshwant Sanzgiri7 AbbVie Inc., North Chicago, IL, USAView further author information
,
David Hoffman7 AbbVie Inc., North Chicago, IL, USAView further author information
,
Ying Zhou7 AbbVie Inc., North Chicago, IL, USAView further author information
,
Jeremy A Ross7 AbbVie Inc., North Chicago, IL, USAView further author information
,
Betty Prine7 AbbVie Inc., North Chicago, IL, USAView further author information
,
Mohamad Shebley7 AbbVie Inc., North Chicago, IL, USAView further author information
,
Megan McNamee7 AbbVie Inc., North Chicago, IL, USAView further author information
,
Thalia Farazi8 Genentech Inc., South San Francisco, CA, USAView further author information
,
Su Young Kim7 AbbVie Inc., North Chicago, IL, USAView further author information
,
Maria Verdugo7 AbbVie Inc., North Chicago, IL, USAView further author information
,
Leanne Lash-Fleming7 AbbVie Inc., North Chicago, IL, USAView further author information
,
C Michel Zwaan9 Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children’s Hospital, Rotterdam, & Princess Máxima Center for Pediatric Oncology, Utrecht, The NetherlandsView further author information
&
Josef Vormoor10 Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University & Great North Children’s Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UKView further author information
 show all
Pages 2115-2129 | Received 09 Feb 2018, Accepted 09 Mar 2018, Published online: 29 Mar 2018

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.